224 related articles for article (PubMed ID: 7524521)
1. The CD19/CD21 signal transduction complex of B lymphocytes.
Tedder TF; Zhou LJ; Engel P
Immunol Today; 1994 Sep; 15(9):437-42. PubMed ID: 7524521
[TBL] [Abstract][Full Text] [Related]
2. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules.
Bradbury LE; Kansas GS; Levy S; Evans RL; Tedder TF
J Immunol; 1992 Nov; 149(9):2841-50. PubMed ID: 1383329
[TBL] [Abstract][Full Text] [Related]
3. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex.
Fearon DT; Carroll MC
Annu Rev Immunol; 2000; 18():393-422. PubMed ID: 10837064
[TBL] [Abstract][Full Text] [Related]
4. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV.
Luxembourg AT; Cooper NR
J Immunol; 1994 Nov; 153(10):4448-57. PubMed ID: 7525704
[TBL] [Abstract][Full Text] [Related]
5. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity.
Fearon DT; Carter RH
Annu Rev Immunol; 1995; 13():127-49. PubMed ID: 7542009
[TBL] [Abstract][Full Text] [Related]
6. CD20: a regulator of cell-cycle progression of B lymphocytes.
Tedder TF; Engel P
Immunol Today; 1994 Sep; 15(9):450-4. PubMed ID: 7524522
[TBL] [Abstract][Full Text] [Related]
7. The CD19 signal transduction complex of B lymphocytes. Deletion of the CD19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-1 and Leu 13.
Bradbury LE; Goldmacher VS; Tedder TF
J Immunol; 1993 Sep; 151(6):2915-27. PubMed ID: 7690791
[TBL] [Abstract][Full Text] [Related]
8. The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system.
Tedder TF; Poe JC; Fujimoto M; Haas KM; Sato S
Curr Dir Autoimmun; 2005; 8():55-90. PubMed ID: 15564717
[TBL] [Abstract][Full Text] [Related]
9. Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19.
Sato S; Miller AS; Howard MC; Tedder TF
J Immunol; 1997 Oct; 159(7):3278-87. PubMed ID: 9317126
[TBL] [Abstract][Full Text] [Related]
10. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
Kozono Y; Abe R; Kozono H; Kelly RG; Azuma T; Holers VM
J Immunol; 1998 Feb; 160(4):1565-72. PubMed ID: 9469411
[TBL] [Abstract][Full Text] [Related]
11. Non-structural determinants of immunogenicity and the B cell co-receptors, CD19, CD21, and CD22.
Fearon DT
Adv Exp Med Biol; 1998; 452():181-4. PubMed ID: 9889972
[No Abstract] [Full Text] [Related]
12. The B lymphocyte as an immunotherapeutic target.
Fearon DT
QJM; 1995 Mar; 88(3):149-53. PubMed ID: 7539331
[No Abstract] [Full Text] [Related]
13. Regulation of lymphocyte activation by the cell-surface molecule CD22.
Law CL; Sidorenko SP; Clark EA
Immunol Today; 1994 Sep; 15(9):442-9. PubMed ID: 7945784
[TBL] [Abstract][Full Text] [Related]
14. Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex.
Rickert RC
Curr Opin Immunol; 2005 Jun; 17(3):237-43. PubMed ID: 15886112
[TBL] [Abstract][Full Text] [Related]
15. The CD24 antigen discriminates between pre-B and B cells in human bone marrow.
Duperray C; Boiron JM; Boucheix C; Cantaloube JF; Lavabre-Bertrand T; Attal M; Brochier J; Maraninchi D; Bataille R; Klein B
J Immunol; 1990 Dec; 145(11):3678-83. PubMed ID: 1700990
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of the B-cell-regulatory molecule CD72 in primary Sjögren's syndrome.
Smith AJ; Gordon TP; Macardle PJ
Tissue Antigens; 2004 Mar; 63(3):255-9. PubMed ID: 14989715
[TBL] [Abstract][Full Text] [Related]
17. Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes.
Matsumoto AK; Martin DR; Carter RH; Klickstein LB; Ahearn JM; Fearon DT
J Exp Med; 1993 Oct; 178(4):1407-17. PubMed ID: 7690834
[TBL] [Abstract][Full Text] [Related]
18. Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells.
Boackle SA; Morris MA; Holers VM; Karp DR
J Immunol; 1998 Dec; 161(12):6537-43. PubMed ID: 9862679
[TBL] [Abstract][Full Text] [Related]
19. B lymphocyte signaling pathways in systemic autoimmunity: implications for pathogenesis and treatment.
Zouali M; Sarmay G
Arthritis Rheum; 2004 Sep; 50(9):2730-41. PubMed ID: 15457440
[No Abstract] [Full Text] [Related]
20. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice.
Rickert RC; Rajewsky K; Roes J
Nature; 1995 Jul; 376(6538):352-5. PubMed ID: 7543183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
